MedGenome presented OncoPept – a point solution in cancer immunotherapy at the Molecular Medicine Tri-Conference 2016

MedGenome presented data on its proprietary cancer immunotherapy platform, OncoPept that predicts and prioritizes T-cell neo-epitopes in human and mouse cancers at the Molecular Medicine Tri- Conference 2016, which took place on March 6– 11, 2016 at San Francisco, CA.